Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0129151 PROTEIN BASED MATERIALS
Gels and films can be formed from protein dissolved into a benign solvent that comprises alcohol, water, and salt. In one example, the protein can be collagen....
2016/0129150 SUGAR CHAIN-POLYPEPTIDE COMPLEX
The object of the present invention is to provide a sugar chain-polypeptide complex that may form a transparent and homogeneous hydrogel in a broad pH. The...
2016/0129149 IMIDATED BIOPOLYMER ADHESIVE AND HYDROGEL
Biologically compatible polymers carry an imide and can be used as an adhesive, a hydrogel or both. A second biologically compatible polymer reactive with the...
2016/0129148 Nano-calcium phosphate-coated polymethylmethacrylate-based co-polymer and coating process of the same
The present invention relates to a method for coating polymethylmethacrylate (PMMA)-based co-polymer beads with nano-calcium phosphate. The method includes...
2016/0129147 SPILL-RESISTANT AIR FRESHENER CANISTER
The present invention provides a spill-resistant air freshener canister that includes: a supply vessel filled with aromatic liquid that has a threaded mouth...
2016/0129146 Device for Diffusing Volatile Substances
The device for diffusing volatile substances, comprising a casing (1) wherein at least two respective volatile substance containers (2) are housed, said...
2016/0129145 METHOD OF NEUTRALIZING MALODORS
A method of neutralizing malodors by providing a malodor control composition having a mixture of volatile aldehydes is provided. In some embodiments, the...
2016/0129144 MALODOR CONTROL COMPOSITION HAVING A MIXTURE OF VOLATILE ALDEHYDES AND METHODS THEREOF
A malodor control composition having a mixture of volatile aldehydes and methods thereof are provided. The composition is suitable for a variety of...
2016/0129143 Odor Elimination System
A odor elimination system includes a pad that may be positioned on a support surface and a carpet is positioned on the pad. An injection unit is provided and...
2016/0129142 SYSTEM AND METHOD FOR REDUCING GERMS BY MEANS OF PLASMA
Disclosed is a system for reducing germs by means of plasma. To this end, a piezoelectric transformer is associated with a dielectric film. The peripheral edge...
2016/0129141 DECONTAMINATION DEVICE FOR MEDICAL MATERIAL
A decontamination device for medical material, including a support intended to receive and hold said medical material to be decontaminated on a predefined...
2016/0129140 Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy
Described herein are compositions and methods of use of radionuclide-antibody conjugates (for RAIT) and drug-antibody conjugates (ADC). The combination of RAIT...
2016/0129139 Method for Purification of 18F-Labeled Choline Analogues
The present invention relates to a method for purification of 18F-labeled choline analogues in a solution injectable to a patient, prepared using non-gaseous...
2016/0129138 OCTAPOD IRON OXIDE NANOPARTICLES AS HIGH PERFORMANCE T2 CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING
Disclosed are nanoparticles comprising octapod iron oxide having eight trigonal bipyramidal arms and a method of preparing the same. The nanoparticles are...
2016/0129137 COMPOSITION FOR MONITORING AGED TISSUES, COMPRISING BACTERIA, AND USE THEREOF
A recombinant bacterium for detecting aged tissues and a method of detecting aged tissues in a subject, and a composition for delivering a drug to aged tissues...
2016/0129136 NOVEL COMPOSITIONS AND USES THEREOF
Compositions comprising one or more nanoparticles, wherein the nanoparticles encapsulate fluorescence dyes are disclosed. In one embodiment, the nanoparticle...
2016/0129135 ONCOLYTIC VACCINIA VIRUS CANCER THERAPY
Embodiments of the invention are directed methods that include a thymidine kinase deficient vaccinia virus. The methods include administering the vaccinia...
2016/0129134 COMPOSITIONS COMPRISING CROSS-LINKED HYALURONIC ACID AND CYCLODEXTRIN
The present invention relates to a hyaluronic acid composition comprising a hyaluronic acid and one or more cyclodextrin molecules covalently bound to said...
2016/0129133 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific...
2016/0129132 Process for Preparing Stealth Nanoparticles
A process for the preparation of targeting nanoparticles of a poly(alkyl cyanoacrylate) homopolymer or copolymer, wherein said method comprises, in a single...
2016/0129131 Shielded Targeting Agents, Methods, and In Vivo Diagnostic System
A system is provided which includes nanoparticle conjugates configured to bind with a tumor cell, the nanoparticle conjugate comprising a nanoparticle, at...
2016/0129130 WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES
Methods for the treatment of CD30-expressing cancers are provided. The methods comprise administering to a subject in need thereof a weekly dose of from about...
2016/0129129 IGG4 FC FRAGMENT COMPRISING MODIFIED HINGE REGION
The present invention relates to a modified IgG4 Fc fragment useful as a drug carrier. When the modified IgG4 Fc fragment of the present invention is combined...
2016/0129128 ANTIBODY DRUG CONJUGATES
Drug conjugates of formula [D-(X)b-(AA)w-(L)-]n-Ab wherein: D is a drug moiety having the following formula (I) or a pharmaceutically acceptable salt, ester,...
2016/0129127 Development of Soluble Albuminated Curcumin for Application in Cancer Therapy
This invention relates to an albumin-curcumin conjugate for application in cancer therapy, including albumin and curcumin.
2016/0129126 CHEMICAL CROSSLINKERS
Disclosed herein are methods of chemical conjugation comprising contacting a lysosomal enzyme with a first crosslinking agent to introduce aldehyde groups;...
2016/0129125 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES
A novel delivery system for drugs, and especially macromolecules such as proteins or oligonucleotides through biological membranes is provided, and...
2016/0129124 Derivatisation of Erythropoietin (EPO)
The present invention relates to a compound which is a polysaccharide derivative of EPO, or of an EPO like protein, wherein the polysaccharide is anionic and...
2016/0129123 Derivatisation of Erythropoietin (EPO)
The present invention relates to a compound which is a polysaccharide derivative of EPO, or of an EPO like protein, wherein the polysaccharide is anionic and...
2016/0129122 FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES
The invention relates to fatty acid antiviral conjugates; compositions comprising an effective amount of a fatty acid antiviral conjugate; and methods for...
2016/0129121 FACTOR VIIA-POLYSIALIC ACID CONJUGATES HAVING PROLONGED IN VIVO HALF-LIFE
The present invention relates to a proteinaceous construct comprising plasmatic or recombinant factor VIIa (FVIIa) or biologically active derivatives thereof,...
2016/0129120 NANOCOMPLEXES OF MODIFIED PEPTIDES OR PROTEINS
A nanocomplex containing a delivery agent and a pharmaceutical agent. The nanocomplex has a particle size of 50 to 1000 nm, the delivery agent binds to the...
2016/0129119 DISPERSION AND METHOD FOR FORMING HYDROGEL
An object is to provide dispersion containing lipid peptide type compound useful as low molecular weight gelator, such as lipid dipeptide and lipid tripeptide,...
2016/0129118 COHESIVE LIQUID BOLUS COMPRISING BIOACTIVES
This invention relates to a cohesive thin liquid bolus comprising an aqueous solution of at least one food grade biopolymer and at least one bioactive...
2016/0129117 Novel Boronic Acid Compound Preparation
The purpose of the present invention is to avoid side effects from contained medicines. Provided are: a preparation obtained by mixing a boronic acid compound...
2016/0129116 Transdermal Drug Delivery using an Osmolyte and Vasoactive Agent
A formulation and method for delivery of bioactive substances when applied to, or within, the skin or other exterior region of a mammal. for example, a...
2016/0129115 FORMULATIONS OF LIQUID STABLE ANTITHROMBIN
In one aspect, the invention provides liquid stable formulations of antithrombin.
2016/0129114 LIQUID COMPOSITION, PROCESS FOR PRODUCING THE LIQUID COMPOSITION, AND ECTOPARASITE CONTROLLING AGENT FOR USE IN...
A liquid composition comprising (a) 21 to 70 parts by weight of a solvent having no nitrogen atom and having a carbonyl or sulfonyl group in the molecule, (b)...
2016/0129113 TABLETS COMPRISING A TASTE MASKING AGENT
The present invention is directed to a tablet comprising at least one bitter tasting and/or mucosa numbness causing pharmaceutically active compound; and at...
2016/0129112 Pharmaceutical Compositions Comprising Pyrophosphate
Described herein are therapeutic compositions comprising a therapeutic agent and pyrophosphate.
2016/0129111 METHODS FOR DELIVERING AN ANTI-CANCER AGENT TO A TUMOR
Described herein are methods for delivering an anti-cancer agent to a tumor in a subject. The method involves administering to the subject (i) gold particles...
2016/0129110 IMMUNOPROTECTIVE PRIMARY MESENCHYMAL STEM CELLS AND METHODS
Immunoprotective primary mesenchymal stems cells (IP-MSC) which episomally express multiple immunoreactive polypeptides that specifically target a pathogen...
2016/0129109 UNIVERSAL ANTI-TAG CHIMERIC ANTIGEN RECEPTOR-EXPRESSING T CELLS AND METHODS OF TREATING CANCER
The present invention provides a universal, yet adaptable, anti-tag chimeric antigen receptor (AT-CAR) system which provides T cells with the ability and...
2016/0129108 THERAPEUTIC COMBINATIONS COMPRISING ANTI-CD73 ANTIBODIES AND USES THEREOF
The present invention provides therapeutic combinations featuring anti-CD73 antibodies (e.g., MEDI9447) and A2A receptor inhibitors and methods of using such...
2016/0129107 MUTATED NON-PRIMATE LENTIVIRAL ENV PROTEINS AND THEIR USE AS DRUGS
A pharmaceutical composition includes, as active substance a mutated non-primate lentiviral Env protein having decreased immunosuppressive properties,...
2016/0129106 Method for preparing virosomes
This disclosure relates to methods for preparing a virosome preparation comprising viral envelope protein of at least two, preferably at least three, more...
2016/0129105 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
The present invention relates to a pharmaceutical composition comprising a modified mRNA that is stabilised by sequence modifications and optimised for...
2016/0129104 HAND, FOOT, AND MOUTH VACCINES AND METHODS OF MANUFACTURE AND USE THEREOF
The present disclosure relates to hand, foot, and mouth disease vaccines and immunogenic compositions having one or more antigens from at least one virus that...
2016/0129103 CHIMERIC INFECTIOUS DNA CLONES, CHIMERIC PORCINE CIRCOVIRUSES AND USES THEREOF
The present invention relates to infectious DNA clones, infectious chimeric DNA clones of porcine circovirus (PCV), vaccines and means of protecting pigs...
2016/0129102 COMPOSITIONS AND METHODS FOR ADMINISTRATION OF VACCINES AGAINST DENGUE VIRUS
Embodiments of the present invention report compositions and methods for vaccinating a subject against dengue viruses. In some embodiments, vaccine...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.